BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 20825441)

  • 1. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
    Desai R; Ross LA; Hoffman JA
    Pediatr Infect Dis J; 2009 Apr; 28(4):283-6. PubMed ID: 19238113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
    Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
    J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
    Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
    Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
    Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
    He H; Ding L; Sun B; Li F; Zhan Q
    Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
    Taghizadeh-Armaki M; Hedayati MT; Moqarabzadeh V; Ansari S; Mahdavi Omran S; Zarrinfar H; Saber S; Verweij PE; Denning DW; Seyedmousavi S
    J Med Microbiol; 2017 Jul; 66(7):898-904. PubMed ID: 28693685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.
    Heng SC; Morrissey O; Chen SC; Thursky K; Manser RL; Nation RL; Kong DC; Slavin M
    Crit Rev Microbiol; 2015 Feb; 41(1):124-34. PubMed ID: 23799871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.